VSee Health Strengthens Balance Sheet With The Elimination of Debt

2 months ago

SAN JOSE, CALIFORNIA / ACCESS Newswire / October 23, 2025 / VSee Health, Inc. (Nasdaq:VSEE), a pioneering force in telehealth…

Florence Connects 65,000+ Study Sites and 600+ Sponsors Worldwide – Unleashing the Next Era of Clinical Trial Intelligence

2 months ago

With the industry's largest network of sites, Florence sets a new benchmark for AI-enabled study startup, workflow automation, and operational…

Telomir Pharmaceuticals Reports New Data Showing Telomir-1 Resets Cancer’s “Kill-and-Clean” Defense Systems in an Aggressive Prostate Cancer Model, Outperforming Rapamycin and Chemo

2 months ago

New findings highlight Telomir-1's impact on CASP8 and GSTP1, two critical genes that regulate cell death and glutathione-based detoxification pathways…

Moderna to Host Investor Event – Analyst Day

2 months ago

CAMBRIDGE, MA / ACCESS Newswire / October 23, 2025 / Moderna, Inc. (Nasdaq:MRNA) today announced that it will host its…

Zomedica Announces Launch of the Assisi Loop Lounge(R), Scientifically Backed tPEMF(TM) Therapy for Pets

2 months ago

Combining peer-reviewed science, superior comfort, and thoughtful design, the Assisi Loop Lounge expands Zomedica's evidence-based therapeutic portfolio and reinforces Assisi's…

Synfini Selected for SLAS 2026 Innovation AveNEW Showcase

2 months ago

Company Selected to Demonstrate its Novel AI Foundry That Unites Virtual and Physical Chemistry, Reducing the Time and Cost of…

Visory Health Partners with Albertsons Companies to Expand Access to Affordable Prescriptions Nationwide

2 months ago

The health tech company adds more than 1,700 Albertsons Cos. pharmacies to its partnership base of over 37,000 locationsESTERO, Fla.,…

SciSparc Targets Quantum-Powered 3D Protein Modeling Technology to Revolutionize AI Drug Discovery

2 months ago

TEL AVIV, Israel, Oct. 23, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (the "Company" or "SciSparc"), a specialty clinical-stage…

Entera Bio Presents Positive New Clinical Data from EB613 Phase 2 Trial Demonstrating Significant Bone Density Improvements in Early Postmenopausal Women

2 months ago

Consistency of BMD gains presented at NAMS 2025 demonstrate EB613’s efficacy in both young postmenopausal women and in women 10…

Silo Pharma Issues Update on Milestone Achievements in PTSD Drug Development and New Digital Assets Treasury Program

2 months ago

Significant milestones are approaching in drug development; additional digital asset purchases expected Preparation for FDA IND application expected to commence…